Tatva Chintan Pharma Chem Ltd vs Vadivarhe Speciality Chemicals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 29, 2026

Key Highlights

The Latest Trading Price of Tatva Chintan Pharma Chem Ltd is ₹ 1101 as of 27 Mar 15:30 . The P/E Ratio of Tatva Chintan Pharma Chem Ltd changed from 53.4 on March 2022 to 278.3 on March 2025 . This represents a CAGR of 51.09% over 4 yearsThe P/E Ratio of Vadivarhe Speciality Chemicals Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Tatva Chintan Pharma Chem Ltd changed from ₹ 5115 crore on March 2022 to ₹ 1588 crore on March 2025 . This represents a CAGR of -25.35% over 4 yearsThe Market Cap of Vadivarhe Speciality Chemicals Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The revenue of Tatva Chintan Pharma Chem Ltd for the Dec '25 is ₹ 133.07 crore as compare to the Sep '25 revenue of ₹ 124.52 crore. This represent the growth of 6.87% The revenue of Vadivarhe Speciality Chemicals Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Tatva Chintan Pharma Chem Ltd for the Dec '25 is ₹ 27.22 crore as compare to the Sep '25 ebitda of ₹ 23.22 crore. This represent the growth of 17.23% The ebitda of Vadivarhe Speciality Chemicals Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Tatva Chintan Pharma Chem Ltd changed from ₹ 5.21 crore to ₹ 15.17 crore over 7 quarters. This represents a CAGR of 84.17% The net profit of Vadivarhe Speciality Chemicals Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Tatva Chintan Pharma Chem Ltd changed from 19.56 % on March 2021 to 708.79 % on March 2025 . This represents a CAGR of 105.04% over 5 yearsThe Dividend Payout of Vadivarhe Speciality Chemicals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Tatva Chintan Pharma Chem Ltd

Tatva Chintan Pharma Chem Limited was formerly incorporated as 'Tatva Chintan Pharma Chem Private Limited' on 12 June 1996.
The status of the Company converted from Private Limited into a Public Limited Company from 27 January 2021 and the name of Company changed from 'Tatva Chintan Pharma Chem Private Limited' to 'Tatva Chintan Pharma Chem Limited'.
The Company is promoted by Mr. Chintan Nitin Kumar Shah, Mr. Ajay Kumar Mansukhlal Patel and Mr. Shekhar Rasiklal Somani. The Company is a globally recognized specialty chemical player with several market leading products in its portfolio.
The Company is primarily engaged in manufacturing, distribution and selling of specialty chemicals i.e., Phase Transfer Catalysts (PTC), Structure Directing Agents (SDA), Electrolyte Salts and Solutions (ESS), Pharmaceutical and Agrochemical Intermediates and Other Specialty Chemicals (PASC).

About Vadivarhe Speciality Chemicals Ltd

Vadivarhe Speciality Chemicals Limited (VSCL) was incorporated on February 23, 2009 and prior to incorporation of the Company, Fem Care Pharma Ltd was promoted by the promoter Mr. Sunil Haripant Pophale which was later taken over by Dabur India Limited in 2009.
Mr. Sunil Haripant Pophale sold his stake in Fem Care Pharma Ltd to Dabur India Limited and as per the terms and condition of the Division Transfer Agreement dated May 07, 2009 the Speciality Chemical Division of Fem Care Pharma Limited was transferred to the Company as a going concern.
After the above transfer, the Company is running the Speciality Chemical Division under the leadership of the Promoter, Mr. Sunil Haripant Pophale. In 2010, the Company started API manufacturing.
In January-2011, Company started a Trading Business of Nutraceutical / Health Supplementary Products which was later discontinued effective from April 01, 2013.

FAQs for the comparison of Tatva Chintan Pharma Chem Ltd and Vadivarhe Speciality Chemicals Ltd

Which company has a larger market capitalization, Tatva Chintan Pharma Chem Ltd or Vadivarhe Speciality Chemicals Ltd?

Market cap of Tatva Chintan Pharma Chem Ltd is 2,576 Cr while Market cap of Vadivarhe Speciality Chemicals Ltd is 27 Cr

What are the key factors driving the stock performance of Tatva Chintan Pharma Chem Ltd and Vadivarhe Speciality Chemicals Ltd?

The stock performance of Tatva Chintan Pharma Chem Ltd and Vadivarhe Speciality Chemicals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Tatva Chintan Pharma Chem Ltd and Vadivarhe Speciality Chemicals Ltd?

As of March 29, 2026, the Tatva Chintan Pharma Chem Ltd stock price is INR ₹1101.5. On the other hand, Vadivarhe Speciality Chemicals Ltd stock price is INR ₹21.15.

How do dividend payouts of Tatva Chintan Pharma Chem Ltd and Vadivarhe Speciality Chemicals Ltd compare?

To compare the dividend payouts of Tatva Chintan Pharma Chem Ltd and Vadivarhe Speciality Chemicals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.